Stay updated with breaking news from Biopharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s share price fell 5% on Monday . The stock traded as low as $99.51 and last traded at $99.51. 16,576 shares were traded during trading, a decline of 63% from the average session volume of 44,738 shares. The stock had previously closed at $104.80. Wall Street Analyst […]
Ranger Investment Management L.P. boosted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,682 shares of the medical instruments supplier’s stock after buying an additional 2,689 shares […]
The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient
He has been president & CEO since June 2020.
Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s stock price fell 5.5% during trading on Thursday . The company traded as low as $110.47 and last traded at $110.47. 17,348 shares changed hands during trading, a decline of 60% from the average session volume of 43,789 shares. The stock had previously closed at $116.84. Analyst […]